AIM ImmunoTech Announces Positive Data from Phase 2a Study E

AIM ImmunoTech Announces Positive Data from Phase 2a Study Evaluating Ampligen® as a Component of a Chemokine Modulatory (CKM) Regimen for the Treatment of Colorectal Cancer Metastatic to the Liver

AIM ImmunoTech Announces Positive Data from Phase 2a Study Evaluating Ampligen® as a Component of a Chemokine Modulatory (CKM) Regimen for the Treatment of Colorectal Cancer Metastatic to the Liver
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Louisiana , United States , New Orleans , American , Pawel Kalinski , Davidr Strayer , Jenene Thomas , Roswell Park , Sarbajit Mukherjee , Roswell Park Comprehensive Cancer Center , American Association For Cancer Research , Immunotech Inc , American Association , Cancer Research , Annual Meeting , Key Findings , Private Securities Litigation Reform Act ,